Literature DB >> 30097493

An exTREMe disruption in Alzheimer's cleanup.

Roger B Dodd1.   

Abstract

Partial loss-of-function variants in the TREM2 immune receptor are associated with increased risk for Alzheimer's disease (AD) and other forms of neurodegenerative disease, but the molecular bases for these connections are unknown. Three new structures of WT and R47H mutant TREM2 immunoglobulin-like (Ig-like) domain now reveal that R47 functions to correctly position elements of the ligand-binding surface. Intriguingly, the authors also demonstrate a disruption of receptor oligomerization by the R47H mutation, suggesting a role for ligand-induced clustering in receptor signaling and resultant plaque clearance.
© 2018 Dodd.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30097493      PMCID: PMC6093237          DOI: 10.1074/jbc.H118.004271

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  10 in total

1.  Molecular basis for the loss-of-function effects of the Alzheimer's disease-associated R47H variant of the immune receptor TREM2.

Authors:  Athena Sudom; Santosh Talreja; Jean Danao; Eric Bragg; Rob Kegel; Xiaoshan Min; Jason Richardson; Zhongqi Zhang; Nikolai Sharkov; Edoardo Marcora; Steve Thibault; Jodi Bradley; Steve Wood; Ai-Ching Lim; Hang Chen; Songli Wang; Ian N Foltz; Shilpa Sambashivan; Zhulun Wang
Journal:  J Biol Chem       Date:  2018-05-24       Impact factor: 5.157

2.  TREM2 Is a Receptor for β-Amyloid that Mediates Microglial Function.

Authors:  Yingjun Zhao; Xilin Wu; Xiaoguang Li; Lu-Lin Jiang; Xun Gui; Yan Liu; Yu Sun; Bing Zhu; Juan C Piña-Crespo; Muxian Zhang; Ningyan Zhang; Xiaochun Chen; Guojun Bu; Zhiqiang An; Timothy Y Huang; Huaxi Xu
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

3.  Elevated TREM2 Gene Dosage Reprograms Microglia Responsivity and Ameliorates Pathological Phenotypes in Alzheimer's Disease Models.

Authors:  C Y Daniel Lee; Anthony Daggett; Xiaofeng Gu; Lu-Lin Jiang; Peter Langfelder; Xiaoguang Li; Nan Wang; Yingjun Zhao; Chang Sin Park; Yonatan Cooper; Isabella Ferando; Istvan Mody; Giovanni Coppola; Huaxi Xu; X William Yang
Journal:  Neuron       Date:  2018-03-07       Impact factor: 17.173

Review 4.  Innate immunity in Alzheimer's disease.

Authors:  Michael T Heneka; Douglas T Golenbock; Eicke Latz
Journal:  Nat Immunol       Date:  2015-03       Impact factor: 25.606

5.  Variant of TREM2 associated with the risk of Alzheimer's disease.

Authors:  Thorlakur Jonsson; Hreinn Stefansson; Stacy Steinberg; Ingileif Jonsdottir; Palmi V Jonsson; Jon Snaedal; Sigurbjorn Bjornsson; Johanna Huttenlocher; Allan I Levey; James J Lah; Dan Rujescu; Harald Hampel; Ina Giegling; Ole A Andreassen; Knut Engedal; Ingun Ulstein; Srdjan Djurovic; Carla Ibrahim-Verbaas; Albert Hofman; M Arfan Ikram; Cornelia M van Duijn; Unnur Thorsteinsdottir; Augustine Kong; Kari Stefansson
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

6.  TREM2 lipid sensing sustains the microglial response in an Alzheimer's disease model.

Authors:  Yaming Wang; Marina Cella; Kaitlin Mallinson; Jason D Ulrich; Katherine L Young; Michelle L Robinette; Susan Gilfillan; Gokul M Krishnan; Shwetha Sudhakar; Bernd H Zinselmeyer; David M Holtzman; John R Cirrito; Marco Colonna
Journal:  Cell       Date:  2015-02-26       Impact factor: 41.582

7.  Neurodegenerative disease mutations in TREM2 reveal a functional surface and distinct loss-of-function mechanisms.

Authors:  Daniel L Kober; Jennifer M Alexander-Brett; Celeste M Karch; Carlos Cruchaga; Marco Colonna; Michael J Holtzman; Thomas J Brett
Journal:  Elife       Date:  2016-12-20       Impact factor: 8.140

8.  Humanized TREM2 mice reveal microglia-intrinsic and -extrinsic effects of R47H polymorphism.

Authors:  Wilbur M Song; Satoru Joshita; Yingyue Zhou; Tyler K Ulland; Susan Gilfillan; Marco Colonna
Journal:  J Exp Med       Date:  2018-01-10       Impact factor: 14.307

9.  The Trem2 R47H variant confers loss-of-function-like phenotypes in Alzheimer's disease.

Authors:  Paul J Cheng-Hathaway; Erin G Reed-Geaghan; Taylor R Jay; Brad T Casali; Shane M Bemiller; Shweta S Puntambekar; Victoria E von Saucken; Roxanne Y Williams; J Colleen Karlo; Miguel Moutinho; Guixiang Xu; Richard M Ransohoff; Bruce T Lamb; Gary E Landreth
Journal:  Mol Neurodegener       Date:  2018-06-01       Impact factor: 14.195

10.  TREM2 variants in Alzheimer's disease.

Authors:  Rita Guerreiro; Aleksandra Wojtas; Jose Bras; Minerva Carrasquillo; Ekaterina Rogaeva; Elisa Majounie; Carlos Cruchaga; Celeste Sassi; John S K Kauwe; Steven Younkin; Lilinaz Hazrati; John Collinge; Jennifer Pocock; Tammaryn Lashley; Julie Williams; Jean-Charles Lambert; Philippe Amouyel; Alison Goate; Rosa Rademakers; Kevin Morgan; John Powell; Peter St George-Hyslop; Andrew Singleton; John Hardy
Journal:  N Engl J Med       Date:  2012-11-14       Impact factor: 91.245

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.